Table 2: Platelet aggregation of patient plasma samples
Sl. No. |
Drug |
No. of |
|
Percentage Aggregation (%) |
|
Patients |
|
|
|
||
|
0 h |
24 h |
|||
|
|
|
|||
|
|
|
|
|
|
1. |
CLP & ASP |
31 |
|
96 |
35 |
|
|
|
|
|
|
2. |
CLP & ASP with |
16 |
|
92 |
71 |
RAB |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
3. |
CLP & ASP with |
9 |
|
94 |
63 |
PAN |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
4. |
CLP & ASP with |
6 |
|
90 |
59 |
RAB & ROS |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
5. |
CLP & ASP with |
9 |
|
96 |
78 |
RAB & SIM |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
6. |
CLP & ASP with |
5 |
|
91 |
70 |
PAN & SIM |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
7. |
CLP & ASP with |
2 |
|
92 |
56 |
PAN & ROS |
|
||||
|
|
|
|
|
|
|
|
|
|
|
|
Note: Average % aggregation in each group in ± SD.